[HTML][HTML] Therapeutic drug monitoring of oral targeted antineoplastic drugs

A Mueller-Schoell, SL Groenland… - European journal of …, 2021 - Springer
Purpose This review provides an overview of the current challenges in oral targeted
antineoplastic drug (OAD) dosing and outlines the unexploited value of therapeutic drug …

Computational oncology—mathematical modelling of drug regimens for precision medicine

D Barbolosi, J Ciccolini, B Lacarelle, F Barlési… - Nature reviews Clinical …, 2016 - nature.com
Computational oncology is a generic term that encompasses any form of computer-based
modelling relating to tumour biology and cancer therapy. Mathematical modelling can be …

[HTML][HTML] The steps to therapeutic drug monitoring: a structured approach illustrated with imatinib

T Buclin, Y Thoma, N Widmer, P André… - Frontiers in …, 2020 - frontiersin.org
Pharmacometric methods have hugely benefited from progress in analytical and computer
sciences during the past decades, and play nowadays a central role in the clinical …

[HTML][HTML] Effect of kidney function on drug kinetics and dosing in neonates, infants, and children

F Rodieux, M Wilbaux, JN van den Anker… - Clinical …, 2015 - Springer
Neonates, infants, and children differ from adults in many aspects, not just in age, weight,
and body composition. Growth, maturation and environmental factors affect drug kinetics …

An insight into medicinal chemistry of anticancer quinoxalines

T Kaushal, G Srivastava, A Sharma, AS Negi - Bioorganic & Medicinal …, 2019 - Elsevier
Quinoxalines are benzopyrazines containing benzene and pyrazine rings fused together. In
the recent past, quinoxalines have attracted Medicinal Chemists considerably for their …

Benchmarking therapeutic drug monitoring software: a review of available computer tools

A Fuchs, C Csajka, Y Thoma, T Buclin… - Clinical pharmacokinetics, 2013 - Springer
Therapeutic drug monitoring (TDM) aims to optimize treatments by individualizing dosage
regimens based on the measurement of blood concentrations. Dosage individualization to …

Metabolism and transport of oxazaphosphorines and the clinical implications

J Zhang, Q Tian, S Yung Chan, S Chuen Li… - Drug metabolism …, 2005 - Taylor & Francis
The oxazaphosphorines including cyclophosphamide (CPA), ifosfamide (IFO), and
trofosfamide represent an important group of therapeutic agents due to their substantial …

A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients

L Rosso, CS Brock, JM Gallo, A Saleem, PM Price… - Cancer research, 2009 - AACR
Difficulties in direct measurement of drug concentrations in human tissues have hampered
the understanding of drug accumulation in tumors and normal tissues. We propose a new …

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure

SE Tett, F Saint-Marcoux, CE Staatz, M Brunet… - Transplantation …, 2011 - Elsevier
This article summarizes part of a consensus meeting about mycophenolate (MPA)
therapeutic drug monitoring held in Rome under the auspices of The Transplantation …

Flat-fixed dosing versus body surface area–based dosing of anticancer drugs in adults: does it make a difference?

RHJ Mathijssen, FA De Jong, WJ Loos… - The …, 2007 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Describe how
and why BSA-based dosing was implemented into oncology. Discuss if flat-fixed dosing of …